AI infrastructure spending is still expanding across chips, cloud capacity, and optical networking, while the IPO market continues to reopen for companies tied to high-growth themes. At the same time, healthcare and financial markets are seeing their own wave of capital formation, strategic deals, and new technology adoption.
How VC Works (Sponsored)
Ready to diversify beyond traditional asset classes? Join the Alumni Ventures team for a quick, high-impact breakdown of venture capital fundamentals.
What You'll Learn:
VC Fundamentals: How venture capital differs from private equity, traditional assets, and why its structure creates the potential for outsized returns.
How Funds Work: How AV builds diversified portfolios across stages, sectors, and funds — and the logic behind each layer.
Who It's For: How accredited investors can access an asset class once reserved for institutions, and what getting started with AV looks like.
Futures at a Glance📈
Futures are mostly flat, with tech holding the edge after AI enthusiasm pushed the Nasdaq to a record. Traders are now looking toward this week’s U.S.-China summit, while rising oil and renewed Fed rate-hike bets are keeping the broader market cautious.
Want to make sure you never miss a pre-market alert?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell.
Email’s great. Texts are faster.
You’ll be first in line when the market starts moving.
What to Watch
Earnings (Premarket):
· AutoZone, Inc. [AZO]
· Thor Industries, Inc. [THO]
· MillerKnoll, Inc. [MLKN]
· Here Group Limited [HERE]
Earnings (Aftermarket):
· KB Home [KBH]
· Worthington Enterprises, Inc. [WOR]
Earnings (Time Not Supplied):
· American Resources Corporation [AREC]
· Espey Mfg. & Electronics Corp. [ESP]
· Elme Communities [ELME]
· ZenaTech, Inc. [ZENA]
Economic Reports:
· Richmond Fed President Thomas Barkin speaks to the CFA Society Baltimore: 1:00 pm
Elite Trade Club Insider
A Director Bought $1 Million While A CEO-Linked Entity Sold $110 Million
You’re looking at one software giant trying to prove AI can accelerate its growth again and one Chinese internet platform posting double-digit revenue growth. Elite Trade Club Insider readers are seeing two very different capital decisions underneath those stories: one director put nearly $1 million of fresh money into his stock, while an entity controlled by another CEO sold roughly $110 million in a single block.
You’re reading the free version. Here’s what we held back.
Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.
A subscription gets you:
The insider buys, options bets, and dark pool moves the free edition can't show you. Unlocked every weekday.
A Sunday Deep Dive that tells you where to look before Monday's bell rings.
The Friday Smart Money Brief: who bought, who sold, where the big options bets landed, and where institutions are hiding volume. Three data layers. One email.
A Monthly Insider Scorecard so you always know whether smart money is buying or selling the market.
Every past Insider edition, unlocked, on elitetrade.club. Go back and see what you missed.
$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.
Market Pulse
Asian tech stocks pushed higher as enthusiasm returned to the AI trade after strong early demand for Meta’s Muse assistant helped lift chipmakers in South Korea and Taiwan; markets are also pricing a higher chance of another Fed rate hike in October.
European markets opened cautiously as traders balanced easing oil fears against higher-rate risks while investors waited for possible U.S.-Iran talks and fresh euro-zone economic data; retail stocks outperformed after Kingfisher raised its full-year profit outlook.
AI & Infrastructure
Alibaba is pushing deeper into the AI stack with a bigger model and a new homegrown chip after unveiling the Zhenwu V900 alongside plans for a model with up to 10 trillion parameters; the company also wants its cloud data-center capacity to exceed 20 gigawatts by 2032.
Ligent Technologies jumped in its Hong Kong debut as AI infrastructure demand keeps pulling in capital after the fiber-optic equipment maker raised about $723 million; more than half of the proceeds are earmarked for R&D into faster optical products and chips.
Healthcare & Biotech
Johnson & Johnson moved closer to expanding one of its key neuroscience drugs after Caplyta met the main goal of a late-stage bipolar mania study; J&J acquired the treatment through its $14.6 billion purchase of Intra-Cellular Therapies last year.
Nvidia-backed Iambic Therapeutics is heading toward the public markets after filing for a U.S. IPO amid a stronger biotech listing cycle; the company uses AI for drug discovery and is developing treatments for solid tumors.
Seven Stocks Screened (Sponsored)
This report focuses on a narrow group of stocks identified through a detailed screening process.
Analysts apply a combination of metrics to narrow down potential opportunities.
Past selections have shown strong momentum, but no outcomes are guaranteed.
The newest edition is now open for access.
Get the report now.
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.
Finance & Deals
Schroders is preparing for the final stretch of its $13.3 billion sale to Nuveen after naming former Goldman Sachs and HSBC banker Matthew Westerman as chairman; the combination will create an asset-management group overseeing roughly $2.5 trillion.
The European Central Bank is bringing blockchain deeper into mainstream finance with a new platform connecting its payments infrastructure to digital securities markets; Deutsche Bank, Santander, and Clearstream are among the first institutions onboarded.
Capital & IPOs
Snapdeal’s parent is cutting its ambitions before hitting India’s public markets as AceVector targets a valuation of roughly $182 million in a trimmed IPO; the company plans to raise about $44 million when subscriptions open later this week.
ADARx Pharmaceuticals is targeting a valuation of up to $1.74 billion as the RNA-drug developer launches its U.S. IPO roadshow; AbbVie has also agreed to invest as much as $100 million alongside the offering.
Movers and Shakers
Vicor [VICR]: Premarket Move: +11%
Vicor surged after the company more than doubled its third-quarter sequential revenue growth outlook, raising guidance from nearly 10% growth to more than 20%. Management credited royalties from its Vertical Power Delivery licensing program, with four major OEMs and hyperscalers now licensing Vicor’s technology as demand for high-density AI power systems accelerates.
Viking Therapeutics [VKTX]: Premarket Move: +7%
Viking Therapeutics climbed after Oppenheimer reiterated its Outperform rating and $100 price target ahead of upcoming VK2735 obesity data. The firm believes the drug’s extended profile could support every-other-week or monthly maintenance dosing, potentially giving Viking another way to differentiate itself in the increasingly crowded weight-loss market.
Quest Diagnostics [DGX]: Premarket Move: −6%
Quest Diagnostics sank after CMS proposed laboratory reimbursement cuts of up to 15% beginning in 2027. The agency estimates Medicare has been paying laboratories roughly 16% more than private insurers, creating a potentially significant earnings headwind for Quest’s large routine-testing business despite Truist simultaneously raising its price target.
Tax Strategy (Sponsored)
Many investors overlook deductions that could help minimize capital gains tax, such as:
Eligible investment expenses
Selling costs tied to property
Each comes with IRS rules and reporting requirements. That’s why consulting a fiduciary financial advisor is often recommended.
See Advisor Matches.
Everything Else
🎯 The Magnificent Seven reshaped the market but seven new contenders are already emerging quietly and a free report names all of them now.
🤖 Meta shares surged after strong demand for its new Muse AI assistant reignited enthusiasm around the company’s push into autonomous AI tools.
💳 Priority Technology agreed to go private for $1.6 billion in a deal led by Chairman and CEO Thomas Priore.
🛢️ Halliburton signed new Venezuela energy agreements with Eneva and WESCA to explore oil and gas development projects in the country.
💾 Intel and Arm Holdings rallied with chip stocks as renewed AI optimism pushed the Nasdaq to another record high.
💊 Novo Nordisk shares fell as management outlined new growth targets and faced questions over pricing, competition and its post-Wegovy pipeline.
You Read This Far. Here's Where the Real Work Lives.
We run three live portfolios on Autopilot, and everything about them is public: every position, every allocation, every trade, visible the moment it happens.
We keep our own money in each one, because analysis you won't fund yourself is just content.
THE UNBREAKABLE STACK
Our growth book: durable software and cybersecurity names built to compound quietly for years.
THE HORMUZ PREMIUM
Our energy thesis: built for how that sector actually pays, over quarters, not headlines.
THE ELON INDEX
Our conviction bet on the Musk universe: Tesla, and the companies orbiting his ventures, energy, AI, infrastructure. High-beta by design, for investors who want direct exposure to the trade rather than watching it from the sidelines.
And here's the part that makes it effortless: Autopilot does the trading for you. Connect the brokerage you already use (Robinhood, Schwab, Fidelity, and more) and every move we make gets mirrored in your own account automatically.
Your money never leaves your brokerage. It stays in your account, under your control, and you can override any trade or disconnect anytime. Autopilot even rebalances automatically when allocations drift, and you get a notification every time something happens.
No watching tickers. No timing entries. No fat-finger mistakes at market open. You pick the portfolio, we do the work, your account follows along.
Pick the one that fits your risk level, or run all three:
Live portfolios, real positions, our own capital at stake. Your funds stay in your own brokerage account. Past performance doesn't guarantee future results.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
